Berenberg analyst Luisa Hector raised the firm’s price target on Sanofi (SNY) to EUR 120 from EUR 115 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNY:
- HHS increasing scrutiny of vaccines under RFK Jr., WSJ reports
- Walgreens downgraded, Cava Group upgraded: Wall Street’s top analyst calls
- Sanofi and Teva Reveal Promising Duvakitug Study Results at ECCO 2025
- NVAX Earnings: Novavax Stock Jumps Despite Mixed Q4 Results
- Sanofi’s Sustained Revenue Growth Potential: Buy Rating Justified by Extended Amvuttra Royalties